Latisse (Bimatoprost) ( CAS 155206-00-1) Market, Global Outlook and Forecast 2022-2028

April 2022 | 71 pages | ID: L0D9732D6AC6EN
Market Monitor Global

Abstracts

Bimatoprost is a medication used to treat high pressure inside the eye including glaucoma.Specifically it is used for open angle glaucoma when other agents are not sufficient.It may also be used to increase the size of the eyelashes. It is used as an eye drop.

This report contains market size and forecasts of Latisse (Bimatoprost) ( CAS 155206-00-1) in global, including the following market information:

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Sales, 2017-2022, 2023-2028, (Kiloton)

Global top five Latisse (Bimatoprost) ( CAS 155206-00-1) companies in 2021 (%)

The global Latisse (Bimatoprost) ( CAS 155206-00-1) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medicine Grade Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Latisse (Bimatoprost) ( CAS 155206-00-1) include Allergan plc (AbbVie Inc.), Sandoz(Novartis), Hi-Tech Pharmacal and Apotex Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Latisse (Bimatoprost) ( CAS 155206-00-1) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Segment Percentages, by Type, 2021 (%)

• Medicine Grade
• Cosmetic Grade

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Segment Percentages, by Application, 2021 (%)

• Medicine
• Cosmetic
• Others

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)

Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) revenues share in global market, 2021 (%)

Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) sales in global market, 2017-2022 (Estimated), (Kiloton)

Key companies Latisse (Bimatoprost) ( CAS 155206-00-1) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan plc (AbbVie Inc.)
• Sandoz(Novartis)
• Hi-Tech Pharmacal
• Apotex Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LATISSE (BIMATOPROST) ( CAS 155206-00-1) OVERALL MARKET SIZE

2.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size: 2021 VS 2028
2.2 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Latisse (Bimatoprost) ( CAS 155206-00-1) Players in Global Market
3.2 Top Global Latisse (Bimatoprost) ( CAS 155206-00-1) Companies Ranked by Revenue
3.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Companies
3.4 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Companies
3.5 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Latisse (Bimatoprost) ( CAS 155206-00-1) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Latisse (Bimatoprost) ( CAS 155206-00-1) Players in Global Market
  3.8.1 List of Global Tier 1 Latisse (Bimatoprost) ( CAS 155206-00-1) Companies
  3.8.2 List of Global Tier 2 and Tier 3 Latisse (Bimatoprost) ( CAS 155206-00-1) Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size Markets, 2021 & 2028
  4.1.2 Medicine Grade
  4.1.3 Cosmetic Grade
4.2 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue & Forecasts
  4.2.1 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2022
  4.2.2 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2023-2028
  4.2.3 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
4.3 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales & Forecasts
  4.3.1 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2022
  4.3.2 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2023-2028
  4.3.3 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
4.4 By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2021 & 2028
  5.1.2 Medicine
  5.1.3 Cosmetic
  5.1.4 Others
5.2 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue & Forecasts
  5.2.1 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2022
  5.2.2 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2023-2028
  5.2.3 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
5.3 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales & Forecasts
  5.3.1 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2022
  5.3.2 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2023-2028
  5.3.3 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
5.4 By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2021 & 2028
6.2 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue & Forecasts
  6.2.1 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2022
  6.2.2 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2023-2028
  6.2.3 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
6.3 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales & Forecasts
  6.3.1 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2022
  6.3.2 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2023-2028
  6.3.3 By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2028
  6.4.2 By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2028
  6.4.3 US Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.4.4 Canada Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.4.5 Mexico Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2028
  6.5.2 By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2028
  6.5.3 Germany Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.5.4 France Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.5.5 U.K. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.5.6 Italy Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.5.7 Russia Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.5.8 Nordic Countries Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.5.9 Benelux Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2028
  6.6.2 By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2028
  6.6.3 China Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.6.4 Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.6.5 South Korea Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.6.6 Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.6.7 India Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2028
  6.7.2 By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2028
  6.7.3 Brazil Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.7.4 Argentina Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, 2017-2028
  6.8.3 Turkey Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.8.4 Israel Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.8.5 Saudi Arabia Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028
  6.8.6 UAE Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Allergan plc (AbbVie Inc.)
  7.1.1 Allergan plc (AbbVie Inc.) Corporate Summary
  7.1.2 Allergan plc (AbbVie Inc.) Business Overview
  7.1.3 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Major Product Offerings
  7.1.4 Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales and Revenue in Global (2017-2022)
  7.1.5 Allergan plc (AbbVie Inc.) Key News
7.2 Sandoz(Novartis)
  7.2.1 Sandoz(Novartis) Corporate Summary
  7.2.2 Sandoz(Novartis) Business Overview
  7.2.3 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Major Product Offerings
  7.2.4 Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales and Revenue in Global (2017-2022)
  7.2.5 Sandoz(Novartis) Key News
7.3 Hi-Tech Pharmacal
  7.3.1 Hi-Tech Pharmacal Corporate Summary
  7.3.2 Hi-Tech Pharmacal Business Overview
  7.3.3 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Major Product Offerings
  7.3.4 Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales and Revenue in Global (2017-2022)
  7.3.5 Hi-Tech Pharmacal Key News
7.4 Apotex Inc.
  7.4.1 Apotex Inc. Corporate Summary
  7.4.2 Apotex Inc. Business Overview
  7.4.3 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Major Product Offerings
  7.4.4 Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales and Revenue in Global (2017-2022)
  7.4.5 Apotex Inc. Key News

8 GLOBAL LATISSE (BIMATOPROST) ( CAS 155206-00-1) PRODUCTION CAPACITY, ANALYSIS

8.1 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Production Capacity, 2017-2028
8.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Production Capacity of Key Manufacturers in Global Market
8.3 Global Latisse (Bimatoprost) ( CAS 155206-00-1) Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LATISSE (BIMATOPROST) ( CAS 155206-00-1) SUPPLY CHAIN ANALYSIS

10.1 Latisse (Bimatoprost) ( CAS 155206-00-1) Industry Value Chain
10.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Upstream Market
10.3 Latisse (Bimatoprost) ( CAS 155206-00-1) Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Latisse (Bimatoprost) ( CAS 155206-00-1) Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Latisse (Bimatoprost) ( CAS 155206-00-1) in Global Market
Table 2. Top Latisse (Bimatoprost) ( CAS 155206-00-1) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Share by Companies, 2017-2022
Table 5. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales by Companies, (Kiloton), 2017-2022
Table 6. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Latisse (Bimatoprost) ( CAS 155206-00-1) Product Type
Table 9. List of Global Tier 1 Latisse (Bimatoprost) ( CAS 155206-00-1) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Latisse (Bimatoprost) ( CAS 155206-00-1) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), 2017-2022
Table 15. By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), 2023-2028
Table 16. By Application – Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), 2017-2022
Table 20. By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), 2023-2028
Table 21. By Region – Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), 2017-2022
Table 25. By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), 2023-2028
Table 26. By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2017-2022
Table 29. By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2023-2028
Table 30. By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2017-2022
Table 33. By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2023-2028
Table 34. By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2017-2022
Table 37. By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2023-2028
Table 38. By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2017-2022
Table 41. By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2023-2028
Table 42. By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2017-2022
Table 45. By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales, (Kiloton), 2023-2028
Table 46. Allergan plc (AbbVie Inc.) Corporate Summary
Table 47. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offerings
Table 48. Allergan plc (AbbVie Inc.) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Sandoz(Novartis) Corporate Summary
Table 50. Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offerings
Table 51. Sandoz(Novartis) Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. Hi-Tech Pharmacal Corporate Summary
Table 53. Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offerings
Table 54. Hi-Tech Pharmacal Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Apotex Inc. Corporate Summary
Table 56. Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Product Offerings
Table 57. Apotex Inc. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales (Kiloton), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Latisse (Bimatoprost) ( CAS 155206-00-1) Production Capacity (Kiloton) of Key Manufacturers in Global Market, 2020-2022 (Kiloton)
Table 59. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Capacity Market Share of Key Manufacturers, 2020-2022
Table 60. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Production by Region, 2017-2022 (Kiloton)
Table 61. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Production by Region, 2023-2028 (Kiloton)
Table 62. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Opportunities & Trends in Global Market
Table 63. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Drivers in Global Market
Table 64. Latisse (Bimatoprost) ( CAS 155206-00-1) Market Restraints in Global Market
Table 65. Latisse (Bimatoprost) ( CAS 155206-00-1) Raw Materials
Table 66. Latisse (Bimatoprost) ( CAS 155206-00-1) Raw Materials Suppliers in Global Market
Table 67. Typical Latisse (Bimatoprost) ( CAS 155206-00-1) Downstream
Table 68. Latisse (Bimatoprost) ( CAS 155206-00-1) Downstream Clients in Global Market
Table 69. Latisse (Bimatoprost) ( CAS 155206-00-1) Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Latisse (Bimatoprost) ( CAS 155206-00-1) Segment by Type
Figure 2. Latisse (Bimatoprost) ( CAS 155206-00-1) Segment by Application
Figure 3. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, 2017-2028 (US$, Mn)
Figure 7. Latisse (Bimatoprost) ( CAS 155206-00-1) Sales in Global Market: 2017-2028 (Kiloton)
Figure 8. The Top 3 and 5 Players Market Share by Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue in 2021
Figure 9. By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 10. By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 13. By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 16. By Region - Global Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 19. US Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 24. Germany Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 25. France Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 33. China Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 37. India Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 40. Brazil Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Latisse (Bimatoprost) ( CAS 155206-00-1) Sales Market Share, 2017-2028
Figure 44. Turkey Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Latisse (Bimatoprost) ( CAS 155206-00-1) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Latisse (Bimatoprost) ( CAS 155206-00-1) Production Capacity (Kiloton), 2017-2028
Figure 49. The Percentage of Production Latisse (Bimatoprost) ( CAS 155206-00-1) by Region, 2021 VS 2028
Figure 50. Latisse (Bimatoprost) ( CAS 155206-00-1) Industry Value Chain
Figure 51. Marketing Channels